Recombinant Vector Shedding
Recombinant Vector Shedding is the release and potential transmission of genetically engineered viral or non-viral delivery systems used in gene therapy from a treated individual into the environment or to other organisms, distinguishing it from endogenous viral shedding by involving exogenous, artificially constructed vectors.
4
Publications
288
Citations
46
Authors
17
Institutions
Publications per year
2017–2026
0
Parents
4
Michel Weber, Joseph E. Rabinowitz, Nathalie Provost et al. · Molecular Therapy · 2003 · 196 citations · Full text
Astrid Pañeda, Esperanza López‐Franco, Christine Kaeppel et al. · Human Gene Therapy · 2013 · 61 citations · Full text
Medicine, Molecular Medicine, Pharmaceutical Biotechnology +14
1–4 of 4
46
1
h-index
1
h-index
1
h-index
The San Raffaele Telethon Institute for Gene Therapy, Italy
1 publications · 14 citations
1
h-index
1
h-index
1–5 of 46
17
Inserm
Paris, France
2 h-index
10 publications
1.6K citations
University of North Carolina at Chapel Hill
Chapel Hill, United States
1 h-index
2 publications
392 citations
The San Raffaele Telethon Institute for Gene Therapy
Milan, Italy
1 h-index
10 publications
140 citations
National Center for Tumor Diseases
Heidelberg, Germany
1 h-index
3 publications
183 citations

École Nationale Vétérinaire de Toulouse
Toulouse, France
1 h-index
1 publications
196 citations

Nantes Université
Nantes, France
1 h-index
1 publications
17 citations
German Cancer Research Center
Heidelberg, Germany
1 h-index
3 publications
183 citations

Children's Hospital of Philadelphia
Philadelphia, United States
1 h-index
1 publications
17 citations
1–8 of 17
1 publications · 196 citations
1
h-index
Book series · 1 publications · 17 citations
1
h-index
1 publications · 14 citations
1
h-index
1 publications · 61 citations
1
h-index
1–4